Official Newsletter of the Utah Poison Control Center 2010 • VOLUME 12 • ISSUE 4 T O D A Y NEW DRUGS FOR TREATMENT OF DIABETES

Source URL: poisoncontrol.utah.edu

• Dipeptidyl peptidase-4 inhibitors
• Eli Lilly and Company
• Amides
• Anti-diabetic drugs
• Peptide hormones
• Exenatide
• Anti-diabetic medication
• Sitagliptin
• Saxagliptin
• Metformin
• Glucagon-like peptide-1 agonist
• Sulfonylurea

glimepiride contraindications glimepiride doses glimepiride dehydration side effects of glimepiride glimepiride forum glimepiride tabs dosage, glimepiride max dose 10mg, glimepiride 2mg

Source URL: observantnomad.com

• Sulfonylureas
• Eli Lilly and Company
• Glimepiride
• Pyrrolines
• Pioglitazone
• Metformin
• Exenatide
• Glibenclamide
• Acarbose

OctoberINSULIN USE FOR TYPE 2 DIABETES MANAGEMENT WHAT INSULIN REGIMEN SHOULD

Source URL: www.medicalpharmacies.com

• Medicine
• Eli Lilly and Company
• Gastroenterology
• Anti-diabetic drugs
• Recombinant proteins
• Exenatide
• Anti-diabetic medication
• Insulin analog
• Insulin glargine
• Endocrine system
• Diabetes
• Peptide hormones

BYDUREON (exenatide extended-release for injectable suspension).

Source URL: www.glucagon.com

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use BYETTA safely and effectively. See full prescribing information for BYETTA. BYETTA姞 (exenatide) Injection Initial

Source URL: www.glucagon.com

7 Tips to Drop Excess Pounds with Diabetes By Sheri Colberg, PhD Losing weight when you have diabetes can be a good newsbad news thing. The good news is that dropping even a few pounds can help reduce your need for diabe

Source URL: www.diabetesincontrol.com

• Health
• Anti-diabetic drugs
• Eli Lilly and Company
• Nutrition
• Recombinant proteins
• Anti-diabetic medication
• Exenatide
• Metformin
• Weight loss
• Medicine
• Endocrine system
• Diabetes

Lyxumia - INN, lixisenatide

Source URL: www.ema.europa.eu

• Medicine
• Gastroenterology
• Diabetes
• Eli Lilly and Company
• Clinical research
• European Medicines Agency
• Anti-diabetic medication
• Exenatide
• Glucagon-like peptide-1
• Anti-diabetic drugs
• Peptide hormones
• Endocrine system

Access to medicines - time for a progressive model Richard Bergström, EFPIA Director General 1

Source URL: www.efpia.eu

• Chemistry
• Liraglutide
• Exenatide
• Anti-diabetic medication
• European Federation of Pharmaceutical Industries and Associations
• Innovation
• Organisation for Economic Co-operation and Development
• Denmark
• Magnesium in biology
• Anti-diabetic drugs
• Europe
• Endocrine system

FOR IMMEDIATE RELEASE INTARCIA AND NUMAB SIGN MULTI-ASSET COLLABORATION TO DEVELOP ONCEYEARLY THERAPIES IN DIABETES, OBESITY, AND AUTOIMMUNE INDICATIONS  Collaboration combines Intarcia’s proprietary delivery tech

Source URL: www.numab.com

• Anatomy
• Biology
• Diabetes
• Anorectics
• Eli Lilly and Company
• Exenatide
• Monoclonal antibodies
• Monoclonal antibody therapy
• Glucagon-like peptide-1
• Anti-diabetic drugs
• Immunology
• Medicine

Optimal glucose control DM Treatment How to Achieve Optimal Glycaemic Control The Tung Wah Eastern Hospital Experience of DM Share Care Experience

Source URL: www.hkma.org

• Anti-diabetic drugs
• Endocrinology
• Peptide hormones
• Blood tests
• Human homeostasis
• Exenatide
• Hypoglycemia
• Blood sugar
• Insulin therapy
• Diabetes
• Endocrine system
• Medicine